Cytokine release regulation

Cytokine release regulation is a complex biological process involving the control of the production, secretion, and signaling of cytokines, which are essential mediators of the immune system. This process is primarily carried out by immune cells such as macrophages, T-cells, and dendritic cells in response to pathogens, tissue injury, or other inflammatory stimuli (Dinarello, 2007). In clinical practice, 'cytokine release regulation' is not a single molecular target but rather a therapeutic objective aimed at preventing or mitigating hyperinflammatory states like cytokine release syndrome (CRS) or chronic autoimmune conditions. Drugs that regulate this process typically target specific components of the inflammatory cascade, such as neutralizing monoclonal antibodies against TNF-alpha or IL-6, or small molecule inhibitors of the JAK-STAT pathway (Shimabukuro-Vornhagen et al., 2018). Proper regulation is vital for maintaining immune homeostasis, as an uncontrolled 'cytokine storm' can lead to systemic vascular leak, multi-organ failure, and death, while excessive suppression can leave the host vulnerable to opportunistic infections (Tanaka et al., 2014).

Other names

Cytokine modulationRegulation of cytokine productionCytokine controlModulation of cytokine synthesis

The regulation of cytokine release is achieved through the pharmacological inhibition of specific pro-inflammatory cytokines (e.g., TNF-alpha, IL-1, IL-6), the blockade of their respective receptors, or the modulation of intracellular signaling cascades such as the JAK-STAT or NF-kappaB pathways to reduce the synthesis and secretion of inflammatory mediators (Shimabukuro-Vornhagen et al., 2018; Tanaka et al., 2014).